Rett Syndrome Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Video
• Funding
• Clinical Trials

A Novel, Regulated Gene Therapy (NGN-401) Study for Female Children With Rett Syndrome
Condition:   Rett Syndrome Intervention:   Genetic: NGN-401 Sponsor:   Neurogene Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2023 Category: Research Source Type: clinical trials

A Novel, Regulated Gene Therapy (NGN-401) Study for Female Children With Rett Syndrome
Condition:   Rett Syndrome Intervention:   Genetic: NGN-401 Sponsor:   Neurogene Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2023 Category: Research Source Type: clinical trials

A Novel, Regulated Gene Therapy (NGN-401) Study for Female Children With Rett Syndrome
Condition:   Rett Syndrome Intervention:   Genetic: NGN-401 Sponsor:   Neurogene Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 12, 2023 Category: Research Source Type: clinical trials

Gene Editing as a Therapeutic Approach for Rett Syndrome
Condition:   Rett Syndrome Intervention:   Other: Gene editing in vitro Sponsor:   University of Siena Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2023 Category: Research Source Type: clinical trials